Home|Journals|Articles by Year|Audio Abstracts
 

Review Article

Mater Sociomed. 2011; 23(1): 36-37


Leukocytosis as a Paraneoplastic Phenomenon in Patients with Malignant Lung Tumors

Bozena Coha, Bozidar Kovacevic, Zvjezdana Boric-Mikez, Milan Bitunjac, Azra Latic.




Abstract

Objective: leukocytosis as a paraneoplastic syndrome may occasionally occur in patients with lung carcinoma. The aim of the study was to assess the prevalence of leukocytosis in our sample of patients with lung carcinoma, to determine if leukocytosis is more common with a particular type of lung carcinoma, and whether leukocytosis caused inappropriate prescribing of antibiotics in patients with lung carcinoma. Methods: The study included 100 lung carcinoma patients treated at Department of Lung Diseases, General Hospital, during a three-year period (2003-2006). The methods of descriptive statistics were used on statistical analysis. Results: during a three-year period (2003-2006), 100 patients with lung carcinoma were treated at General Hospital, 23% of them with leukocytosis as a paraneoplastic phenomenon. Antibiotic therapy was prescribed in five of 23 (1,25%) patients. Conclusion: leukocytosis was most frequently associated with squamous cell carcinoma of the lung (43%), however, without statistical significance. Antibiotic therapy was prescribed in 1,25% of leukocytosis patients, suggesting that leukocytosis was correctly recognized as a araneoplastic phenomenon and was not unnecessarily treated with antibiotics.

Key words: leukocytosis, lung carcinoma






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.